SCHEMBL19397481

SCHEMBL19397481

c1ccc(-c2ccc(-c3cc(-c4cccc(-c5cccc6ccccc56)c4)nc(-c4ccc(-c5cccnc5)cc4)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
MAPT P10636 6/20 0.50
HPGD P15428 6/20 0.50
KDM4E B2RXH2 6/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
RAB9A P51151 2/20 0.50
DHODH Q02127 1/20 0.50
CYP19A1 P11511 2/20 0.48
TNF P01375 1/20 0.47
CYP11B1 P15538 2/20 0.46
CYP17A1 P05093 1/20 0.44
CYP11B2 P19099 1/20 0.44
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
GLA P06280 3/20 0.44
LMNA P02545 2/20 0.44
CYP2C9 P11712 3/20 0.42
TSHR P16473 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30296922 0.97 ALDH1A1 (0.50) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17808138 0.97 ALDH1A1 (0.50) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL30296872 0.96 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17808146 0.96 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17917888 0.96 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17807973 0.96 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17808142 0.96 DHODH (0.49) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL17808049 0.96 KDM4E (0.51) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL19397428 0.96 ALDH1A1 (0.54) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2
SCHEMBL30297006 0.96 KDM4E (0.51) ALDH1A1MAPTHPGDKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM ALDH1A1 129/4885MAPT 3242/4885HPGD 3527/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 ALDH1A1 226/4885MAPT 3912/4885HPGD 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.